Developed by the neuroscience innovators at Binaural Technologies, Brain Song uses gamma wave entrainment and BDNF activation ...

According to one of the organizations, Indivisible, nearly 500,000 people were signed up to protest across all 50 states ...

Janux Therapeutics' lead drug, JANX007, shows promising prostate cancer results with no serious side effects. Find out why ...

Furthermore, its high FCF margin allows the company to be debt-free and hold a cash hoard of over $600 million. Generating ...

As the days get longer and the weather warms up, it’s the perfect time to get your bike ready for the season,” according to a news release. “Join the Northcentral Pennsylvania Conservancy and ...

Research analysts at Leerink Partnrs cut their Q1 2025 earnings per share (EPS) estimates for shares of Maze Therapeutics in ...

Xilio Therapeutics (NASDAQ:XLO – Get Free Report) is projected to announce its earnings results before the market opens on Monday, April 7th. Analysts expect the company to announce earnings of ($0.22 ...

LENZ Therapeutics (LENZ) has filed to sell 13M shares of common stock for holders. This prospectus is not an offer to sell. Filing ...

AIM ImmunoTech Inc. (“AIM” or the “Company”) (NYSE American: AIM), an immuno-pharma company focused on the research and ...

Dark Blue Therapeutics, a UK discovery and development biotech developing precision oncology medicines, has announced the appointment of Edwin Moses as chairman.

John Beeler, Ph.D., SVP of Business Development at BPGbio, brings over two decades of experience in biotechnology and ...

Scientists found that pseudouridine helps small RNAs pass on traits and avoid immune detection, offering clues for future RNA ...